Literature DB >> 18299448

A functional 14-3-3zeta-independent association of PI3-kinase with glycoprotein Ib alpha, the major ligand-binding subunit of the platelet glycoprotein Ib-IX-V complex.

Fi-Tjen Mu1, Robert K Andrews, Jane F Arthur, Adam D Munday, Susan L Cranmer, Shaun P Jackson, Frank C Stomski, Angel F Lopez, Michael C Berndt.   

Abstract

Engagement of the adhesion receptor glycoprotein (GP) Ib-IX-V by von Willebrand factor (VWF) mediates platelet adhesion to damaged vessels and triggers platelet activation and thrombus formation in heart attack and stroke. GPIb-IX-V contains distinct 14-3-3zeta-binding sites at the GPIb alpha C-terminus involving phosphorylation of Ser609, an upstream site involving phosphorylated Ser587/Ser590, and a protein kinase A (PKA)-dependent site on GPIb beta involving Ser166. 14-3-3zeta regulates the VWF-binding affinity of GPIb-IX-V and inhibiting 14-3-3zeta association blocks receptor signaling, suggesting a key functional role for 14-3-3zeta. We used deletion mutants of GPIb alpha expressed in Chinese hamster ovary (CHO) cells to define the relationship of 14-3-3zeta binding to another GPIb-IX-V-associated signaling protein, phosphoinositide 3-kinase (PI3-kinase). Pull-down experiments involving glutathione S-transferase (GST)-PI3-kinase/p85-subunit and GST-14-3-3zeta indicated that both proteins interacted with contiguous GPIb alpha sequences 580 to 590/591 to 610. Deleting these, but not upstream sequences of GPIb alpha expressed in CHO cells, inhibited VWF/ristocetin-dependent Akt phosphorylation, relative to wild-type receptor, confirming this region encompassed a functional PI3-kinase-binding site. Pull-down experiments with GST-p85 truncates indicated the GPIb alpha-binding region involved the p85 breakpoint cluster region (BCR) domain, containing RSXSXP. However, pull-down of GPIb-IX was unaltered by mutation/deletion/phosphorylation of this potential 14-3-3zeta-binding sequence in mutant constructs of GST-p85, suggesting PI3-kinase bound GPIb alpha independently of 14-3-3zeta; 14-3-3zeta inhibitor peptide R18 also blocked pull-down of receptor by GST-14-3-3zeta but not GST-p85, and GST-p85 pull-downs were unaffected by excess 14-3-3zeta. Together, these data suggest the GPIb alpha C-terminus regulates signaling through independent association of 14-3-3zeta and PI3-kinase.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18299448      PMCID: PMC2343594          DOI: 10.1182/blood-2007-09-111096

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  40 in total

1.  Cytoplasmic domains of GpIbalpha and GpIbbeta regulate 14-3-3zeta binding to GpIb/IX/V.

Authors:  S Feng; N Christodoulides; J C Reséndiz; M C Berndt; M H Kroll
Journal:  Blood       Date:  2000-01-15       Impact factor: 22.113

2.  Essential role for phosphoinositide 3-kinase in shear-dependent signaling between platelet glycoprotein Ib/V/IX and integrin alpha(IIb)beta(3).

Authors:  Cindy L Yap; Karen E Anderson; Sascha C Hughan; Sacha M Dopheide; Hatem H Salem; Shaun P Jackson
Journal:  Blood       Date:  2002-01-01       Impact factor: 22.113

Review 3.  New responsibilities for the PI3K regulatory subunit p85 alpha.

Authors:  K Okkenhaug; B Vanhaesebroeck
Journal:  Sci STKE       Date:  2001-01-16

4.  Requirement of leucine-rich repeats of glycoprotein (GP) Ibalpha for shear-dependent and static binding of von Willebrand factor to the platelet membrane GP Ib-IX-V complex.

Authors:  Y Shen; G M Romo; J F Dong; A Schade; L V McIntire; D Kenny; J C Whisstock; M C Berndt; J A López; R K Andrews
Journal:  Blood       Date:  2000-02-01       Impact factor: 22.113

5.  Interaction of calmodulin with the cytoplasmic domain of the platelet membrane glycoprotein Ib-IX-V complex.

Authors:  R K Andrews; A D Munday; C A Mitchell; M C Berndt
Journal:  Blood       Date:  2001-08-01       Impact factor: 22.113

6.  The cytoplasmic domain of the platelet glycoprotein Ibalpha is phosphorylated at serine 609.

Authors:  R J Bodnar; M Gu; Z Li; G D Englund; X Du
Journal:  J Biol Chem       Date:  1999-11-19       Impact factor: 5.157

7.  Phosphoinositide 3-kinase forms a complex with platelet membrane glycoprotein Ib-IX-V complex and 14-3-3zeta.

Authors:  A D Munday; M C Berndt; C A Mitchell
Journal:  Blood       Date:  2000-07-15       Impact factor: 22.113

8.  Interaction between platelet glycoprotein Ibalpha and filamin-1 is essential for glycoprotein Ib/IX receptor anchorage at high shear.

Authors:  David Williamson; Inna Pikovski; Susan L Cranmer; Pierre Mangin; Nayna Mistry; Teresa Domagala; Sam Chehab; Francois Lanza; Hatem H Salem; Shaun P Jackson
Journal:  J Biol Chem       Date:  2001-11-07       Impact factor: 5.157

9.  The role of Akt in the signaling pathway of the glycoprotein Ib-IX induced platelet activation.

Authors:  Hong Yin; Aleksandra Stojanovic; Nissim Hay; Xiaoping Du
Journal:  Blood       Date:  2007-10-03       Impact factor: 22.113

10.  Platelet glycoprotein ibalpha is a counterreceptor for the leukocyte integrin Mac-1 (CD11b/CD18).

Authors:  D I Simon; Z Chen; H Xu; C Q Li; J f Dong; L V McIntire; C M Ballantyne; L Zhang; M I Furman; M C Berndt; J A López
Journal:  J Exp Med       Date:  2000-07-17       Impact factor: 14.307

View more
  15 in total

Review 1.  14-3-3 proteins in platelet biology and glycoprotein Ib-IX signaling.

Authors:  Yunfeng Chen; Zaverio M Ruggeri; Xiaoping Du
Journal:  Blood       Date:  2018-04-05       Impact factor: 22.113

Review 2.  Signaling mechanisms of the platelet glycoprotein Ib-IX complex.

Authors:  Yaping Zhang; Samuel M Ehrlich; Cheng Zhu; Xiaoping Du
Journal:  Platelets       Date:  2022-05-26       Impact factor: 4.236

3.  Akt-mediated platelet apoptosis and its therapeutic implications in immune thrombocytopenia.

Authors:  Mengxing Chen; Rong Yan; Kangxi Zhou; Xiaodong Li; Yang Zhang; Chunliang Liu; Mengxiao Jiang; Honglei Ye; Xingjun Meng; Ningbo Pang; Lili Zhao; Jun Liu; Weiling Xiao; Renping Hu; Qingya Cui; Wei Zhong; Yunxiao Zhao; Mingqing Zhu; Anning Lin; Changgeng Ruan; Kesheng Dai
Journal:  Proc Natl Acad Sci U S A       Date:  2018-10-18       Impact factor: 11.205

Review 4.  Platelets and cancer: a casual or causal relationship: revisited.

Authors:  David G Menter; Stephanie C Tucker; Scott Kopetz; Anil K Sood; John D Crissman; Kenneth V Honn
Journal:  Cancer Metastasis Rev       Date:  2014-03       Impact factor: 9.264

5.  Src family tyrosine kinase Lyn mediates VWF/GPIb-IX-induced platelet activation via the cGMP signaling pathway.

Authors:  Hong Yin; Junling Liu; Zhenyu Li; Michael C Berndt; Clifford A Lowell; Xiaoping Du
Journal:  Blood       Date:  2008-06-11       Impact factor: 22.113

Review 6.  Src family kinases: at the forefront of platelet activation.

Authors:  Yotis A Senis; Alexandra Mazharian; Jun Mori
Journal:  Blood       Date:  2014-08-12       Impact factor: 22.113

7.  Role of 14-3-3ζ in platelet glycoprotein Ibα-von Willebrand factor interaction-induced signaling.

Authors:  Weilin Zhang; Lili Zhao; Jun Liu; Juan Du; Rong Yan; Kesheng Dai
Journal:  Int J Mol Sci       Date:  2012-05-02       Impact factor: 6.208

Review 8.  Of von Willebrand factor and platelets.

Authors:  Marijke Bryckaert; Jean-Philippe Rosa; Cécile V Denis; Peter J Lenting
Journal:  Cell Mol Life Sci       Date:  2014-10-09       Impact factor: 9.261

Review 9.  Structure-function of platelet glycoprotein Ib-IX.

Authors:  M Edward Quach; Renhao Li
Journal:  J Thromb Haemost       Date:  2020-08-24       Impact factor: 16.036

10.  Flow cytometric analysis of platelets type 2 diabetes mellitus reveals 'angry' platelets.

Authors:  Prashilla Soma; Albe Carina Swanepoel; Jeanette Noel du Plooy; Thandi Mqoco; Etheresia Pretorius
Journal:  Cardiovasc Diabetol       Date:  2016-03-31       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.